Marshall Wace’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-518,008
| Closed | -$7.49M | – | 3360 |
|
|
2026
Q1 | $7.49M | Buy |
518,008
+277,108
| +115% | +$3.97M | 0.01% | 1107 |
|
|
2025
Q4 | $3.43M | Buy |
+240,900
| New | +$2.37M | ﹤0.01% | 1326 |
|
|
2025
Q3 | – | Sell |
-15,062
| Closed | -$86.3K | – | 3040 |
|
|
2025
Q2 | $86.3K | Sell |
15,062
-181,051
| -92% | -$1.17M | ﹤0.01% | 2559 |
|
|
2025
Q1 | $1.6M | Buy |
196,113
+123,145
| +169% | +$1.14M | ﹤0.01% | 1564 |
|
|
2024
Q4 | $687K | Buy |
72,968
+52,368
| +254% | +$544K | ﹤0.01% | 1904 |
|
|
2024
Q3 | $220K | Buy |
+20,600
| New | +$224K | ﹤0.01% | 2265 |
|
|
2023
Q4 | – | Sell |
-62,114
| Closed | -$755K | – | 2310 |
|
|
2023
Q3 | $755K | Buy |
+62,114
| New | +$801K | ﹤0.01% | 1585 |
|
|
2021
Q3 | – | Sell |
-16,945
| Closed | -$163K | – | 3148 |
|
|
2021
Q2 | $163K | Buy |
+16,945
| New | +$165K | ﹤0.01% | 2483 |
|
|
2021
Q1 | – | Sell |
-47,199
| Closed | -$1.09M | – | 2598 |
|
|
2020
Q4 | $1.09M | Buy |
+47,199
| New | +$965K | 0.01% | 1179 |
|
|
2019
Q3 | – | Sell |
-742,236
| Closed | -$9.26M | – | 1755 |
|
|
2019
Q2 | $9.26M | Buy |
742,236
+573,235
| +339% | +$7.27M | 0.08% | 303 |
|
|
2019
Q1 | $2.3M | Buy |
169,001
+10,911
| +7% | +$133K | 0.02% | 700 |
|
|
2018
Q4 | $1.51M | Sell |
158,090
-1,007,851
| -86% | -$11.1M | 0.02% | 797 |
|
|
2018
Q3 | $14.1M | Buy |
+1,165,941
| New | +$16.3M | 0.12% | 227 |
|
|
2016
Q3 | – | Sell |
-64,107
| Closed | -$350K | – | 1004 |
|
|
2016
Q2 | $350K | Buy |
+64,107
| New | +$448K | ﹤0.01% | 880 |
|
|
2015
Q4 | – | Sell |
-42,224
| Closed | -$591K | – | 1018 |
|
|
2015
Q3 | $591K | Sell |
42,224
-283,044
| -87% | -$4.44M | 0.01% | 713 |
|
|
2015
Q2 | $4.6M | Sell |
325,268
-870,246
| -73% | -$10.5M | 0.06% | 312 |
|
|
2015
Q1 | $13M | Sell |
1,195,514
-73,715
| -6% | -$650K | 0.17% | 155 |
|
|
2014
Q4 | $10.6M | Buy |
+1,269,229
| New | +$8.71M | 0.14% | 186 |
|
|
2014
Q3 | – | Sell |
-339,443
| Closed | -$1.13M | – | 928 |
|
|
2014
Q2 | $1.13M | Buy |
+339,443
| New | +$797K | 0.02% | 488 |
|
Other funds holding FOLD
Marshall Wace's FOLD Position: Q2 2026 in Review
Marshall Wace sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 518,008 shares — an estimated $7.49M sold.
Marshall Wace first reported a position in FOLD in Q2 2014 and held it in 19 quarters. The position peaked at $14.1M in Q3 2018. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Marshall Wace reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Marshall Wace sold 518,008 Amicus Therapeutics shares in Q2 2026, an estimated $7.49M.
- Marshall Wace first reported a position in Amicus Therapeutics in Q2 2014 and held it in 19 quarters.
- Marshall Wace's Amicus Therapeutics position peaked at $14.1M in Q3 2018.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.